1,804 results on '"Després, Jean-Pierre"'
Search Results
202. PAI-1 activity, but not fibrinogen or von Willebrand factor, is inversely related to LDL particle size in type 2 diabetes
203. Glucose homeostasis predicts weight gain: prospective and clinical evidence
204. Efficacy and Safety of Rimonabant for Improvement of Multiple Cardiometabolic Risk Factors in Overweight/Obese Patients: Pooled 1-year data from the Rimonabant in Obesity (RIO) program
205. Type 2 Diabetes Without the Atherogenic Metabolic Triad Does Not Predict Angiographically Assessed Coronary Artery Disease in Women
206. Cholesterol levels in small LDL particles predict the risk of coronary heart disease in the EPIC-Norfolk prospective population study
207. Visceral Adipose Tissue Accumulation, Cardiorespiratory Fitness, and Features of the Metabolic Syndrome
208. The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential
209. How effective is rimonabant at promoting and maintaining weight loss in patients with obesity?
210. Health Conditions and Resource Use of Abdominally Obese Subjects with Type 2 Diabetes: 2402-PO
211. Hepatic Lipase Gene Variant −514C>T Is Associated With Lipoprotein and Insulin Sensitivity Response to Regular Exercise: The HERITAGE Family Study
212. Insulin resistance syndrome, body mass index and the risk of ischemic heart disease
213. Adiponectinemia in Visceral Obesity: Impact on Glucose Tolerance and Plasma Lipoprotein and Lipid Levels in Men
214. Modifications in food-group consumption are related to long-term body-weight changes
215. Évaluation de la prise en charge des diabétiques de type 2
216. Endothelin-1 levels and cardiovascular risk factors in renal transplant patients
217. Genetic aspects of susceptibility to obesity and related dyslipidemias
218. What is a Normal Glucose Value?: Differences in indexes of plasma glucose homeostasis in subjects with normal fasting glucose
219. Race and Sex Similarities in Exercise-Induced Changes in Blood Lipids and Fatness
220. Eating behaviours, dietary profile and body composition according to dieting history in men and women of the Québec Family Study
221. Contribution of Visceral Adiposity to the Exaggerated Postprandial Lipemia of Men With Impaired Glucose Tolerance
222. Contribution of apo CIII reduction to the greater effect of 12-week micronized fenofibrate than atorvastatin therapy on triglyceride levels and LDL size in dyslipidemic patients
223. Long-Term Adiposity Changes Are Related to a Glucocorticoid Receptor Polymorphism in Young Females
224. Aging Per Se Does Not Influence Glucose Homeostasis: In vivo and in vitro evidence
225. Plasma organochlorine concentrations in endurance athletes and obese individuals
226. Effects of prednisone withdrawal on the new metabolic triad in cyclosporine-treated kidney transplant patients
227. 5′ Flanking Variants of Resistin Are Associated With Obesity
228. Micronized Fenofibrate: A Viewpoint by Jean-Pierre Després
229. Total Cholesterol/HDL Cholesterol Ratio vs LDL Cholesterol/HDL Cholesterol Ratio as Indices of Ischemic Heart Disease Risk in Men: The Quebec Cardiovascular Study
230. Evaluation and management of atherogenic dyslipidemia: beyond low-density lipoprotein cholesterol
231. Age and Duration of Follow-up as Modulators of the Risk for Ischemic Heart Disease Associated With High Plasma C-Reactive Protein Levels in Men
232. Health consequences of visceral obesity
233. Deterioration of the Metabolic Risk Profile in Women: Respective contributions of impaired glucose tolerance and visceral fat accumulation
234. A Genome-Wide Scan for Abdominal Fat Assessed by Computed Tomography in the Québec Family Study
235. Age-Related Differences in Messenger Ribonucleic Acid Expression of Key Proteins Involved in Adipose Cell Differentiation and Metabolism*
236. High Carbohydrate and High Monounsaturated Fatty Acid Diets Similarly Affect LDL Electrophoretic Characteristics in Men Who Are Losing Weight
237. Relationship between sex hormone-binding globulin levels and features of the metabolic syndrome
238. Calcium intake, body composition, and lipoprotein-lipid concentrations in adults
239. Contributors
240. The utility of the international child and adolescent overweight guidelines for predicting coronary heart disease risk factors
241. Genome-wide linkage analysis for circulating levels of adipokines and C-reactive protein in the Quebec family study (QFS)
242. Metabolic Heterogeneity Underlying Postprandial Lipemia among Men with Low Fasting High Density Lipoprotein Cholesterol Concentrations*
243. Fasting Insulin Levels Influence Plasma Leptin Levels Independently from the Contribution of Adiposity: Evidence from Both a Cross-Sectional and an Intervention Study*
244. Contribution of Body Fatness and Adipose Tissue Distribution to the Age Variation in Plasma Steroid Hormone Concentrations in Men: The HERITAGE Family Study*
245. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association.
246. Apolipoprotein E polymorphism and the relationships of physical fitness to plasma lipoprotein-lipid levels in men and women
247. Expression of the androgen metabolizing enzyme UGT2B15 in adipose tissue and relative expression measurement using a competitive RT-PCR method
248. Cardiovascular risk scoring and magnetic resonance imaging detected subclinical cerebrovascular disease
249. From syndrome X to cardiometabolic risk: clinical and public health implications
250. Effect of PPARγ agonist on aerobic exercise capacity in relation to body fat distribution in men with type 2 diabetes mellitus and coronary artery disease: a 1-yr randomized study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.